NAVX-010-Phase I Tolerability and Pharmacokinetic Study in Healthy Male Subjects

NCT03655522 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety

Interventions

DRUG: NAVX-010
DRUG: Placebo

Sponsor

Algenis SpA

Collaborators

[object Object]